Novavax, Inc. (NVAX)
10.78
+1.00
(+10.22%)
USD |
NASDAQ |
Nov 06, 16:00
10.74
-0.04
(-0.37%)
After-Hours: 20:00
Novavax Market Cap : 1.777B for Nov. 6, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 06, 2026 | 1.777B |
| November 05, 2026 | 1.612B |
| November 04, 2026 | 1.755B |
| November 03, 2026 | 1.595B |
| November 02, 2026 | 1.571B |
| October 30, 2026 | 1.661B |
| October 29, 2026 | 1.726B |
| October 28, 2026 | 1.701B |
| October 27, 2026 | 1.651B |
| October 26, 2026 | 1.549B |
| October 23, 2026 | 1.599B |
| October 22, 2026 | 1.647B |
| October 21, 2026 | 1.815B |
| October 20, 2026 | 1.884B |
| October 19, 2026 | 1.783B |
| October 16, 2026 | 1.856B |
| October 15, 2026 | 2.113B |
| October 14, 2026 | 2.083B |
| October 13, 2026 | 2.113B |
| October 12, 2026 | 2.087B |
| October 09, 2026 | 2.101B |
| October 08, 2026 | 1.815B |
| October 07, 2026 | 1.849B |
| October 06, 2026 | 1.866B |
| October 05, 2026 | 2.070B |
| Date | Value |
|---|---|
| October 02, 2026 | 1.724B |
| October 01, 2026 | 1.747B |
| September 30, 2026 | 1.782B |
| September 29, 2026 | 1.783B |
| September 28, 2026 | 1.780B |
| September 25, 2026 | 1.752B |
| September 24, 2026 | 1.747B |
| September 23, 2026 | 1.739B |
| September 22, 2026 | 1.785B |
| September 21, 2026 | 1.716B |
| September 18, 2026 | 1.666B |
| September 17, 2026 | 1.648B |
| September 16, 2026 | 1.541B |
| September 15, 2026 | 1.521B |
| September 14, 2026 | 1.581B |
| September 11, 2026 | 1.553B |
| September 10, 2026 | 1.533B |
| September 09, 2026 | 1.623B |
| September 08, 2026 | 1.679B |
| September 04, 2026 | 1.684B |
| September 03, 2026 | 1.704B |
| September 02, 2026 | 1.701B |
| September 01, 2026 | 1.668B |
| August 31, 2026 | 1.544B |
| August 28, 2026 | 1.526B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Moderna, Inc. | 101.42B |
| Merck & Co., Inc. | 361.95B |
| Pfizer Inc. | 167.52B |
| Amgen, Inc. | 249.04B |
| Editas Medicine, Inc. | 394.57M |
Market Cap Related Metrics
| PS Ratio | 4.308 |
| Price | 10.78 |
| Earnings Yield | -4.33% |